Search Login Register
Sleep-Wake Transition Disorders
(Sleep Talking)
Summary
42
relevant articles (11 outcomes,
10 trials/studies)
found for this Disease
Description:
Parasomnias characterized by behavioral abnormalities that occur during the transition between wakefulness and sleep (or between sleep and wakefulness).
Also Known As:
Sleep Talking; Jactatio Capitis Nocturna; Movement Disorders, Rhythmic Nocturnal; Nocturnal Sleep Head Banging; Rhythmic Movement Disorders, Nocturnal Show All >>
Key Drugs and Agents for Sleep-Wake Transition Disorders
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Quinine (Quinson)
:
9 outcomes 8 studies in 32 results
:
FDA 2
-
Magnesium
:
2 outcomes 1 study in 2 results
: IBA
-
Vitamin E
:
1 outcome 1 study in 3 results
:
FDA 12
-
Vitamin B Complex (B Vitamins)
:
1 outcome 1 study in 1 result
: IBA
-
Riboflavin (Vitamin B2)
:
1 outcome 1 study in 1 result
:
FDA 8
-
Pyridoxal Phosphate (Pyridoxal 5 Phosphate)
:
1 outcome 1 study in 1 result
: IBA
-
Hydroxocobalamin
:
1 outcome 1 study in 1 result
:
FDA 6
-
Verapamil (Calan)
:
1 study in 2 results
:
FDA 7
Generic
-
Limptar
:
2 results
: IBA
-
Theophylline (Theon)
:
1 result
:
FDA 117
Generic
Show All >>
Diseases Related to Sleep-Wake Transition Disorders
-
Hypertension (High Blood Pressure)
-
Malaria
-
Fever (Fevers)
-
Thrombocytopenia (Thrombopenia)
-
Muscle Cramp (Cramp)
Show All >>
Key Therapies for Sleep-Wake Transition Disorders
Efficacy Chart >>
-
Ambulatory Care (Outpatient Care)
:
1 result
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.